symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
LVCLY,0.062,0.852559,1782,14465220,0,0.03-0.09,0.0006,Living Cell Technologies Limited,USD,,US53838R1077,,Other OTC,PNK,Biotechnology,https://www.lctglobal.com,"Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.",Mr. David Richard Hainsworth,Healthcare,AU,,61 3 8689 9997,Tower 2,Sydney,NSW,2000,,0,https://financialmodelingprep.com/image-stock/LVCLY.png,2008-01-30,False,False,True,False,False
